Home / World / World Lifestyle / Archive by category Health & Medical (Page 2)

Archive by category Health & Medical

FAAM-EUROBAT 2024 Concludes with Groundbreaking Advances in Food Allergy and Anaphylaxis Research

ATHENS, Greece, Dec. 12, 2024 (Korea Bizwire) – FAAM-EUROBAT 2024, held from 21-23 November at the InterContinental Athenaeum Athens, brought over 550 attendees from over 25 countries to share the latest advancements in food allergy and anaphylaxis research. The event featured impactful sessions, debates, workshops, and plenary discussions, highlighting new evidence and the importance of collaboration in tackling [...]

Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases

Company on track to deliver five Investigational New Drug (IND) applications as part of ‘5 by 5’ solid tumor strategy 18 months ahead of original target Nomination of ZW209, a novel trispecific T cell engager, as fifth development candidate in the Company’s solid tumor portfolio Expansion into autoimmune and inflammatory diseases (AIID) and hematology oncology [...]

Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street

Provides significant resources to build on diversified portfolio of established and rare disease medicines Egham, UK – 12 December 2024 – Essential Pharma (“Essential” or “the Company”), an international specialty pharma group focused on ensuring that patients have access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic areas, today announces the completion of [...]

Io Therapeutics, Inc., Announces Presentation of Data from Studies of Its RAR Gamma Agonist Compound IRX5010 in Treatment of a Mouse Model of Triple Negative Breast Cancer, Demonstrating Combination Treatment Effects with an Anti-PDL-1 Monoclonal Antibody Checkpoint Inhibitor

The combination treatment resulted in increased numbers of anti-cancer tumor-infiltrating T-cells; decreased numbers of anti-cancer response inhibiting tumor-infiltrating myeloid derived suppressor cells; and substantial 84% inhibition of tumor growth SPRING, Texas, Dec. 11 (Korea Bizwire) — Io Therapeutics, Inc., presented results from studies done in a mouse model of triple negative breast cancer with the [...]

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinics The program, launching this month, will run for a minimum of three years PARSIPPANY, N.J., Dec. 11, 2024 (Korea Bizwire) – Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a new patient access [...]

GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors

Former CEO of NPS Pharma brings strong biotech expertise to further accelerate GEn1E’s development and commercialization of dual signal modulators as novel precision therapies PALO ALTO, Calif., Dec. 11, 2024 (Korea Bizwire) – GEn1E Lifesciences (GEn1E), a clinical-stage, Phase 2 company, focused on accelerating novel therapies for inflammatory and rare diseases using machine learning, is [...]

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer

AIV001 is currently in development for evaluation in Superficial and Nodular Superficial Basal Cell Carcinoma (sBCC and nBCC) COSA MESA, Calif., Dec. 09, 2024 (Korea Bizwire) – AiViva Biopharma Inc., a clinical-stage biotechnology company, announced the receipt of FDA clearance for testing AIV001 (axitinib) by intradermal injection with their formulation in facial skin. AIV001 is [...]

Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial

AJOVY® (fremanezumab) significantly reduced monthly migraine days (MMD) and monthly headache days (MHD) versus placebo over a 12-week period in pediatric patients aged 6-17 years1 Efficacy consistent with fremanezumab pivotal Phase 3 and Real-World Evidence studies in adults with no new emergent safety signals observed Full data presented as a late breaker at European Headache Congress (EHC) 4-7 December in [...]

Philips aims to advance cardiac MRI technology through AI-driven research

December 3, 2024 Collaboration intends to leverage proprietary AI technology from Philips and Mayo Clinic to target breakthroughs in ease-of-use and efficiency to bring high-quality diagnostic MRI and better care to more patients with heart disease Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic today announced a research collaboration aimed at advancing [...]

Canon Medical Informatics Selected by Major Non-Profit Health System to Standardize Advanced Visualization Across 25+ Locations

MINNETONKA, Minn., Dec. 03, 2024 (Korea Bizwire) – Canon Medical Informatics, Inc. today announced that a leading non-profit health system in the Mid-Atlantic region has chosen Canon’s Vitrea® Advanced Visualization enterprise platform to consolidate its 3D imaging capabilities across more than 25 sites. This transition from a multi-vendor setup to a unified, integrated solution will help [...]